The update discusses the latest information on Pfizer's COVID-19 vaccine, including details on the new technology, storage requirements, logistics handling, and Emergency Use Authorization (EUA). Pfizer's vaccine, with a 95% efficacy rate, requires storage in ultra-low-temperature freezers or therma

0 views • 28 slides

Learn about the upcoming Live Virtual Training session accredited for continuing education credits in various medical fields. Registration is required before the deadline to ensure participation and credit completion. Discover valuable information regarding the Pfizer-BioNTech COVID-19 Vaccine recom

1 views • 9 slides

In the latest VASE+ Release 11.4, several new features have been introduced to enhance vaccine management processes. These include a new vaccine selection field, Pfizer vaccine lot addition for 5-11-year-olds, color coding per vaccine type, customizability options, new columns for vaccine name and s

0 views • 8 slides

Stay informed about the latest updates on bivalent booster vaccines including Pfizer and Moderna for pediatric and adolescent populations. Learn about eligibility criteria, dosage, storage, and handling instructions. Find out more about the vaccination process, recommended spacing between doses, and

0 views • 19 slides

Understanding the significance of business ethics, codes of conduct, and professionalism is crucial in today's corporate world. The intertwining concepts of ethics and professionalism play a vital role in shaping organizational culture, fostering trust among stakeholders, and avoiding damaging conse

0 views • 20 slides

COVID-19 vaccines play a crucial role in preventing illness by helping the body develop immunity to the SARS-CoV-2 virus. Vaccines like Pfizer-BioNTech and Moderna utilize mRNA technology to trigger the immune system to produce antibodies against the virus. These vaccines are safe, effective, and pr

0 views • 15 slides

COVID-19 vaccination is crucial in reducing the likelihood of infection, severe illness, and spread of the virus. Almost everyone over 6 months should get vaccinated, except those with severe allergies to vaccine components. The Pfizer-BioNTech, Moderna, and Novavax vaccines are safe and effective.

0 views • 14 slides

Pfizer and Moderna vaccine updates for different age groups, Novavax administration, clinical updates, and myocarditis/pericarditis updates were discussed in the Alpha Office Hours meeting scheduled for June 16, 2022. The agenda also included Vaccine Finder and July 4th shipping updates. The timelin

0 views • 31 slides

Spillovers and linkages play a crucial role in the impact of development projects in Connecticut. Projects like Hartford's Adrian's Landing Waterfront development have led to increased tourism and economic growth. While some areas like Hartford's Downtown are benefiting from revitalization, challeng

0 views • 42 slides

Pfizer provides additional flexibility for scheduling appointments for children turning 12, introduces a new vaccine record for Pfizer 12+, enhances call center and public-facing scheduling, allows boosters for AstraZeneca primary series recipients, and adds special accommodation questions for schoo

0 views • 7 slides

Discussing factors influencing COVID-19 vaccine acceptance, surveys on hesitancy, perspectives of older adults, and strategies for addressing concerns. Details on Pfizer and Moderna vaccines, efficacy data, side effects, and subgroup analyses are provided.

0 views • 17 slides

A detailed agenda of the LI NAPNAP chapter meeting at Blackstone Steakhouse featuring topics on novel prescription options for atopic dermatitis, Pfizer Pharmaceuticals' informational program, partnerships for vulnerable youth, community service projects, scholarships, and more.

0 views • 15 slides

New updates regarding COVID-19 vaccine administration and recommendations have been released, including the ability for clinics to create and manage vaccine supplies for children as young as six months. The Western States Scientific Review Workgroup supports the use of Moderna and Pfizer-BioNTech bi

0 views • 6 slides

In the latest update, Dr. Thomas Dobbs emphasizes the importance of COVID-19 vaccination for individuals above 4 years old, with special attention to those above 11 years old. Updated vaccines like Pfizer, Moderna, and Novavax are recommended, with a reminder for those due for vaccination since Sept

0 views • 12 slides

Patients with COVID-19 are at higher risk of thrombotic events, and antithrombotic regimens have shown varied results in previous trials. The APOLLO trial investigated the use of apixaban for prophylaxis in outpatients with additional risk factors. Results indicated that low-dose apixaban did not si

0 views • 18 slides